Influence of atrial fibrillation on plasma von Willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure

被引:30
作者
Freestone, Bethan [1 ]
Gustasson, Finn
Chong, Aun Yeong [1 ]
Corell, Pernille [2 ]
Kistorp, Caroline [3 ]
Hildebrandt, Per [4 ]
Lip, Gregory Y. H. [1 ]
机构
[1] City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7HQ, W Midlands, England
[2] Frederiksberg Univ Hosp, Dept Cariol & Endocrinol E, Frederiksberg, Denmark
[3] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark
[4] Roskilde Univ Hosp, Dept Med, Roskilde, Denmark
关键词
atrial fibrillation; heart failure; N-terminal pro B-type natriuretic peptide; von Willebrand factor;
D O I
10.1378/chest.07-2557
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Endothelial dysfunction is present in patients with heart failure (HF) due to left ventricular systolic dysfunction, as well as in patients with atrial fibrillation (AF) who have normal cardiac function. it is unknown whether AF influences the degree of endothelial dysfunction in patients with systolic HF. Methods: We measured levels of plasma von Willebrand factor (vWF) and E-selectin (as indexes of endothelial damage/dysfunction and endothelial activation, respectively; both enzyme-linked immunosorbent assay) in patients with AF and HF (AF-HF), who were compared to patients with sinus rhythm and HF (SR-HF), as well as in age-matched, healthy, control subjects. We also assessed the relationship of vWF and E-selectin to plasma N-terminal pro B-type natriuretic peptide (NTpro-BNP), a marker for HF severity and prognosis. Results: One hundred ninety patients (73% men; mean age, 69.0 +/- 10.1 years [+/- SD]) with systolic HF were studied, who were compared to 117 healthy control subjects: 52 subjects (27%) were in AF, while 138 subjects (73%) were in sinus rhythm. AF-HF patients were older than SR-HF patients (p = 0.046), but left ventricular ejection fraction and New York Heart Association class were similar. There were significant differences in NT-proBNP (p < 0.0001) and plasma vWF (p = 0.003) between patients and control subjects. On Tukey post hoe analysis, AF-HF patients had significantly increased NT-proBNP (p < 0.001) and vWF (p = 0.0183) but not E-selectin (p = 0.071) levels when compared to SR-HF patients. On multivariate analysis, the presence of AF was related to plasma vWF levels (p = 0.018). Plasma vWF was also significantly correlated with NT-proBNP levels (Spearman r = 0.139; p = 0.0117). Conclusions: There is evidence of greater endothelial damage/dysfunction in AF-HF patients when compared to SR-HF patients. The clinical significance of this is unclear but may have prognostic value.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 50 条
  • [31] Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide
    Yasuyuki Shiraishi
    Toshiyuki Nagai
    Shun Kohsaka
    Ayumi Goda
    Yuji Nagatomo
    Atsushi Mizuno
    Takashi Kohno
    Alan Rigby
    Keiichi Fukuda
    Tsutomu Yoshikawa
    Andrew L. Clark
    John G. F. Cleland
    Clinical Research in Cardiology, 2018, 107 : 1103 - 1110
  • [32] Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide
    Shiraishi, Yasuyuki
    Nagai, Toshiyuki
    Kohsaka, Shun
    Goda, Ayumi
    Nagatomo, Yuji
    Mizuno, Atsushi
    Kohno, Takashi
    Rigby, Alan
    Fukuda, Keiichi
    Yoshikawa, Tsutomu
    Clark, Andrew L.
    Cleland, John G. F.
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (12) : 1103 - 1110
  • [33] Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
    H Villacorta
    ET Mesquita
    M Montera
    Critical Care, 9 (Suppl 2):
  • [34] Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction
    Vanderheyden, M.
    Bartunek
    Claeys, G.
    Manoharan, G.
    Beckers, J. F.
    Ide, L.
    CLINICAL BIOCHEMISTRY, 2006, 39 (06) : 640 - 645
  • [35] The role of N-terminal pro-B-type natriuretic peptide in prognostic evaluation of heart failure
    Lam, Carolyn S. P.
    Li, Yi-Heng
    Bayes-Genis, Antoni
    Ariyachaipanich, Aekarach
    Do Quang Huan
    Sato, Naoki
    Kahale, Pravin
    Ta Manh Cuong
    Dong, Yugang
    Li, Xinli
    Zhou, Yanli
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 447 - 451
  • [36] N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
    Schnorbach, Johannes
    Froehlich, Hanna
    Taeger, Tobias
    Corletto, Anna
    Katus, Hugo A.
    Frankenstein, Lutz
    ESC HEART FAILURE, 2019, 6 (04): : 640 - 648
  • [37] Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation
    Roldan, Vanessa
    Antonio Vilchez, Juan
    Manzano-Fernandez, Sergio
    Jover, Eva
    Galvez, Josefa
    Puche, Carmen M.
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    Marin, Francisco
    STROKE, 2014, 45 (03) : 696 - 701
  • [38] Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure
    Adlbrecht, Christopher
    Huelsmann, Martin
    Neuhold, Stephanie
    Strunk, Guido
    Pacher, Richard
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (05) : 533 - 538
  • [39] Comparison of the Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Death and Cardiovascular Events: Superiority of N-Terminal Pro-B-Type Natriuretic Peptide
    McKie, Paul
    Cataliotti, Alessandro
    Sangaralingham, S. J.
    Ichiki, Tomoko
    Redfield, Margaret
    Chen, Horng
    Rodeheffer, Richard
    Burnett, John
    CIRCULATION, 2010, 122 (21)
  • [40] Plasma N-terminal atrial natriuretic peptide predicts hospitalization in patients with heart failure
    Dickstein, K
    Abrahamsen, S
    Aarsland, T
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1998, 32 (06) : 361 - 364